About: Marie Wislez

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Marie Wislez Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідниця (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy)
rdfs:label	Marie Wislez (en) Marie Wislez (es) Marie Wislez (nl) Marie Wislez (pt) Marie Wislez (pt-br) Marie Wislez (ast)
skos:prefLabel	Marie Wislez (en) Marie Wislez (es) Marie Wislez (nl) Marie Wislez (pt) Marie Wislez (pt-br) Marie Wislez (ast)
name	Marie Wislez (en) Marie Wislez (es) Marie Wislez (nl) Marie Wislez (pt) Marie Wislez (pt-br) Marie Wislez (ast)
given name	wds:Q56549715-1EA10C28-5427-44DF-BF38-CA35C058EDCA
given name	Marie
instance of	wds:Q56549715-4AE61EE4-BD2F-4A56-8F35-B2E119503611
instance of	Homo sapiens
occupation	wds:Q56549715-3BC806A0-FF21-4825-A9E6-2ADA13BB627E
employer	wds:Q56549715-1814B73D-E68F-4CD8-8428-2C074BFE1BC6 wds:Q56549715-49FAD10F-39EE-48BF-800C-CD3DFD59CFC1 wds:Q56549715-4F80456C-63DD-4519-9617-5274BFBFD7D2 wds:Q56549715-9DD722F0-E3AD-4B08-AF1A-9E33B7A04495
sex or gender	wds:Q56549715-eb093f47-d174-4a21-82de-62887a8f82fb
ISNI	wds:Q56549715-86D893E7-2C2F-40F1-AFB6-21DE5AE89725
VIAF ID	wds:Q56549715-09021700-7CD3-414D-8A27-D392D9DA4256
IdRef ID	wds:Q56549715-150EEC71-C196-4DD0-9840-783FC336A055
educated at	wds:Q56549715-25841A4F-A503-454E-8503-29659D1C7E69 wds:Q56549715-3CBC4A25-539E-4583-9E59-DFD11FE6D465
VIAF ID	http://viaf.org/viaf/214239980
IdRef ID	http://www.idref.fr/089425774/id
occupation	researcher
employer	Assistance Publique – Hôpitaux de Paris Paris Descartes University Sorbonne Universités
sex or gender	female organism
ISNI	0000000139470155
VIAF ID	214239980
IdRef ID	089425774
educated at	Paris Descartes University Sorbonne Universités
ORCID iD	wds:Q56549715-BB0D766D-4C93-4BE1-97C0-0D8347BD876C
ORCID iD	https://orcid.org/0000-0001-7518-7859
ORCID iD	0000-0001-7518-7859
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56549715
is author of	Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives Lung cancer in HIV infected patients: facts, questions and challenges. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature Primary pulmonary lymphoma French Intensive Care Society, International congress - Réanimation 2016 Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. A simple view on lung cancer biology: The EGFR pathway High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor Release of metal particles from needles used for transbronchial needle aspiration [A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blocker]. Prospective screening for ALK: clinical features and outcome according to ALK status. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma. AIDS-related primary pulmonary lymphoma. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancer. [Pulmonary sarcomatoid carcinoma] Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Human RNA polymerase II associated factor 1 complex promotes tumorigenesis by activating c-MYC transcription in non-small cell lung cancer [Cystic opacity of the posterior mediastinum] Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism. Pathological complete response: A predictive survival factor after neoadjuvant chemotherapy in lung cancer Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers. Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy [Respiratory manifestations of common variable immunodeficiency in adults]

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software